Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -21.31% vs 1.67% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -6.56% vs 19.38% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 9.04% vs 25.00% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 156.25% vs -33.33% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Enanta Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -16.28% vs -7.53% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -21.31% vs 1.67% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -48.85% vs -10.08% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -6.56% vs 19.38% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -51.89% vs -6.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 9.04% vs 25.00% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 24.24% vs 6.45% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 156.25% vs -33.33% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






